Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...
Q4 2024 Management View CEO Martin Lyons highlighted strong operational and financial results for 2024, including adjusted earnings of $4.63 per share, exceeding the midpoint of their guidance range.
Pharmaceuticals giant GlaxoSmithKline (GSK.L) (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss ... “Our outperformance and stronger balance sheet ...
Insider Monkey on MSN17h
eGain Corporation (NASDAQ:EGAN) Q2 2025 Earnings Call TranscriptOperator: Hello, and welcome to the eGain Corporation Fiscal 2025 Second Quarter Financial Results Call. All participants ...
Pharmaceuticals giant GlaxoSmithKline (GSK.L) (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline ... and stronger balance sheet support these investments and ...
has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” performance in 2024. The company revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback